ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer.

Anne F Schott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.